Leit í EES-gagnagrunni
Commission Implementing Decision (EU) 2024/1066 of 5 April 2024 amending the Annex to Implementing Decision (EU) 2023/2447 concerning emergency measures in relation to outbreaks of highly pathogenic avian influenza in certain Member States
Commission Implementing Decision (EU) 2024/1039 of 2 April 2024 concerning certain interim emergency measures relating to African swine fever in Bulgaria
Commission Implementing Decision (EU) 2024/865 of 18 March 2024 specifying the values relating to the performance of manufacturers and pools of manufacturers of new passenger cars and new light commercial vehicles for the calendar year 2022 pursuant to Regulation (EU) 2019/631 of the European Parliament and of the Council
Commission Implementing Decision (EU) 2024/852 of 8 March 2024 amending the Annex to Implementing Decision (EU) 2023/2447 concerning emergency measures in relation to outbreaks of highly pathogenic avian influenza in certain Member States
D095068/01
Commission Implementing Decision (EU) 2024/888 of 22 March 2024 on the non-approval of certain active substances for use in biocidal products in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council
Commission Decision (EU) 2024/721 of 27 February 2024 establishing, pursuant to Directive 2000/60/EC of the European Parliament and of the Council, the values of the Member State monitoring system classifications as a result of the intercalibration exercise and repealing Commission Decision (EU) 2018/229
Commission Implementing Decision (EU) 2024/773 of 4 March 2024 amending Decision 2009/992/EU as regards minimum requirements for additional data to be entered in the national electronic register of road transport undertakings
Commission Implementing Decision (EU) 2024/766 of 1 March 2024 amending Implementing Decision (EU) 2019/1119 as regards the calculation of the CO2 savings and of the statistical margin for certain not off-vehicle charging hybrid electric passenger cars
Commission Implementing Decision (EU) 2024/759 of 23 February 2024 amending the Annex to Implementing Decision (EU) 2023/2447 concerning emergency measures in relation to outbreaks of highly pathogenic avian influenza in certain Member States
Commission Implementing Decision (EU) 2024/586 of 16 February 2024 amending and correcting Implementing Decision (EU) 2023/2432 as regards the determination of reference values for certain producers and importers for the period from 1 January 2024 to 31 December 2024
Commission Implementing Decision (EU) 2024/580 of 9 February 2024 amending the Annex to Implementing Decision (EU) 2023/2447 concerning emergency measures in relation to outbreaks of highly pathogenic avian influenza in certain Member States
Commission Decision (EU) 2024/560 of 8 December 2023 granting the Kingdom of Spain a derogation from certain provisions of Regulation (EU) 2019/943 of the European Parliament and of the Council and of Directive (EU) 2019/944 of the European Parliament and of the Council as regards the Canary Islands
D094983/01
Commission Implementing Decision (EU) 2024/732 of 28 February 2024 postponing the expiry date of the approval of aluminium phosphide for use in biocidal products of product-types 14 and 18 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council
D094022/02
Commission Implementing Decision (EU) 2024/731 of 28 February 2024 postponing the expiry date of the approval of indoxacarb for use in biocidal products of product-type 18 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council
D094984/01
Commission Implementing Decision (EU) 2024/787 of 28 February 2024 postponing the expiry date of the approval of magnesium phosphide for use in biocidal products of product-type 18 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council
D094927/01
Commission Implementing Decision (EU) 2024/734 of 27 February 2024 postponing the expiry date of the approval of brodifacoum, bromadiolone, chlorophacinone, coumatetralyl, difenacoum, difethialone and flocoumafen for use in biocidal products of product-type 14 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council
D094023/02
Commission Implementing Decision (EU) 2024/733 of 28 February 2024 postponing the expiry date of the approval of cholecalciferol for use in biocidal products of product-type 14 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council
D094026/02
Commission Implementing Decision (EU) 2024/816 of 5 March 2024 addressing questions regarding the second comparative assessment of anticoagulant rodenticide biocidal products in accordance with Article 23(5) of Regulation (EU) No 528/2012 of the European Parliament and of the Council
Commission Implementing Decision (EU) 2024/459 of 1 February 2024 on setting up the European Digital Infrastructure Consortium for Networked Local Digital Twins towards the CitiVERSE (LDT CitiVERSE EDIC)
Commission Implementing Decision (EU) 2024/458 of 1 February 2024 on setting up the European Digital Infrastructure Consortium for the Alliance for Language Technologies (ALT-EDIC)
Commission Implementing Decision (EU) 2024/416 of 25 January 2024 amending the Annex to Implementing Decision (EU) 2023/2447 concerning emergency measures in relation to outbreaks of highly pathogenic avian influenza in certain Member States
Commission Implementing Decision (EU) 2024/411 of 30 January 2024 on the list of shipping companies specifying the administering authority in respect of a shipping company in accordance with Directive 2003/87/EC of the European Parliament and of the Council
Commission Implementing Decision (EU) 2024/391 of 26 January 2024 authorising the placing on the market of products containing, consisting of or produced from genetically modified maize Bt11 × MIR162 × MIR604 × MON 89034 × 5307 × GA21 and thirty sub-combinations, pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council
Commission Implementing Decision (EU) 2024/389 of 26 January 2024 renewing the authorisation for the placing on the market of products containing, consisting of or produced from genetically modified oilseed rape Ms8, Rf3 and Ms8 × Rf3 pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council
Commission Implementing Decision (EU) 2024/388 of 26 January 2024 amending Implementing Decision (EU) 2021/1385 as regards the scope extension of the authorisation and repealing Implementing Decision (EU) 2015/701